Replimune Group

(NASDAQ) REPL

Current Price$5.22

Market Cap$431.03M

Since IPO (2018)-66%

5 Year-85%

1 Year-28%

1 Month+129%

Replimune Group Financials at a Glance

Market Cap

$431.03M

Revenue (TTM)

$0.00

Net Income (TTM)

$314.85M

EPS (TTM)

$-3.58

P/E Ratio

-1.46

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$5.22

Volume

5,875,124.345

Open

$4.90

Price

$5.22

Volume

5,875,124.345

Open

$4.90

Previous Close

$5.22

Daily Range

$4.75 - $5.41

52-Week Range

$1.50 - $13.24

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$5.22

Volume

5,875,124.345

Open

$4.90

Previous Close

$5.22

Daily Range

$4.75 - $5.41

52-Week Range

$1.50 - $13.24

REPL News

Two people participating in a telehealth session

REPL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Replimune Group

Industry

Biotechnology

Sector

Health Care

Employees

479

CEO

Sushil Patel, PhD

Website

www.replimune.com

Headquarters

Woburn, MA 01801, US

REPL Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-91%

Return on Capital

-1%

Return on Assets

-94%

Earnings Yield

-68.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$431.03M

Shares Outstanding

82.57M

Volume

5.88M

Avg. Volume

5.80M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$261.63M

EBITDA

$253.92M

Operating Cash Flow

$192.25M

Capital Expenditure

$6.69M

Free Cash Flow

$198.94M

Cash & ST Invst.

$483.80M

Total Debt

$76.17M

Replimune Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$431.03M

N/A

Market Cap/Employee

$899.85K

N/A

Employees

479

N/A

Net Income

$70.93M

-6.9%

EBITDA

$67.95M

-4.6%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Net Cash

$192.79M

-58.1%

Accounts Receivable

$2.96M

-3.6%

Inventory

$0.00

N/A

Long Term Debt

$72.27M

+0.2%

Short Term Debt

$4.08M

+3.3%

Return on Assets

-94.38%

N/A

Return on Invested Capital

-1.15%

N/A

Free Cash Flow

$66.09M

-25.9%

Operating Cash Flow

$65.95M

-30.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

DNAGinkgo Bioworks Holdings, Inc.

DNAGinkgo Bioworks Holdings, Inc.$7.71-1.78%

VALNValneva SE

VALNValneva SE$5.68-4.38%

PRMEPrime Medicine, Inc.

PRMEPrime Medicine, Inc.$2.93-6.39%

ARVNArvinas, Inc.

ARVNArvinas, Inc.$9.08-3.61%

MGTXMeiraGTx Holdings plc

MGTXMeiraGTx Holdings plc$9.40-5.53%

MBXMBX Biosciences, Inc. Common Stock

MBXMBX Biosciences, Inc. Common Stock$32.45-8.23%

IOVAIovance Biotherapeutics, Inc.

IOVAIovance Biotherapeutics, Inc.$3.45-1.99%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

Questions About REPL

What is the current price of Replimune Group?

Replimune Group is trading at $5.22 per share.

What is the 52-week range for Replimune Group?

Over the past 52 weeks, Replimune Group has traded between $1.50 and $13.24.

How much debt does Replimune Group have?

As of the most recent reporting period, Replimune Group reported total debt of $76.35M.

How much cash does Replimune Group have on hand?

Replimune Group reported $122.95M in cash and cash equivalents in its most recent financial results.

What is Replimune Group’s dividend yield?

Replimune Group does not currently have a dividend yield.

Replimune Group

Replimune Group Financials at a Glance

REPL News

Why Replimune Stock Was Soaring Today

Why Replimune Stock Was Tumbling Again Today

Why Replimune Stock Plummeted by Almost 40% Today

Replimune (REPL) Q1 Loss Widens 61%

2 Biotech Stocks That Could Have Tripled Your Money This Year

2 Top Biotech Stocks From the IPO Class of 2018 to Buy Now

Why Replimune Stock Is Soaring Today

REPL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Replimune Group

REPL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Replimune Group Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About REPL

What is the current price of Replimune Group?

What is the 52-week range for Replimune Group?

How much debt does Replimune Group have?

How much cash does Replimune Group have on hand?

What is Replimune Group’s dividend yield?

Premium Investing Services